La Sociedad Cubana de Inmunología apoya la lucha internacional contra la pandemia de COVID-19, y presenta una relación de recursos de información relacionados con la respuesta inmune a SARS-CoV-2. Los artículos que siguen a continuación están disponibles a texto completo, publicados desde el 1º de marzo de 2020. Agradeceremos las contribuciones de otros trabajos que sean igualmente de libre acceso.
183. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J Exp Med 2021;218(5):e20202617.
182. Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection. JAMA Intern Med., 2021; doi:10.1001/jamainternmed.2021.0366.
181. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19. A Systematic Review and Meta-analysis. JAMA, 2021; doi:10.1001/jama.2021.2747.
180. SARS-CoV-2 Vaccines. JAMA, 2021; doi:10.1001/jama.2021.3199.
179. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell, 2021; https://doi.org/10.1016/j.cell.2021.01.037.
178. Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. The Lancet, 2021; https://doi.org/10.1016/S0140-6736(21)00501-8.
177. Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine. The Lancet, 2021; https://doi.org/10.1016/S0140-6736(21)00502-X.
176. COVID-19 vasculitis and novel vasculitis mimics. The Lancet Rheumatology, 2021;3(3):e224-e233.
175. Perspective of patients with autoimmune diseases on COVID-19 vaccination. The Lancet Rheumatology, 2021; https://doi.org/10.1016/S2665-9913(21)00037-0.
174. Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases. The Lancet Rheumatology, 2021; https://doi.org/10.1016/S2665-9913(21)00039-4.
173. COVID-19 cytokine storm: targeting the appropriate cytokine. The Lancet Rheumatology, 2021; https://doi.org/10.1016/S2665-9913(21)00011-4.
172. Assessing the importance of interleukin-6 in COVID-19. The Lancet Respiratory Medicine, 2021;9(2):e13.
171. Herd immunity for COVID-19. The Lancet Respiratory Medicine 2021;9(2):135-13. https://www.sciencedirect.com/science/article/pii/S2213260020305555
170. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine. JAMA. 2021;325(8):780–781.
169. Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021. JAMA, 2021; doi:10.1001/jama.2021.1967.
168. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ 2020;370:m2516.
167. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J Exp Med 7 December 2020;217(12):e20201241.
166. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol August 15, 2020;205(4)915-922.
165. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections. J Immunol August 15, 2020;205(4)892-898.
164. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front. Immunol., 16 June 2020; https://doi.org/10.3389/fimmu.2020.01441.
163. Demand for BCG Vaccine Due to Unproven Claims of its Role in Preventing COVID-19 Is Causing Shortages of Vaccines for Infants in Japan. Pediatr Infect Dis J. 2020 Jul;39(7):e159–e160.
162. Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty. 2020;9:108.
161. Comparison of different serological assays for SARS-CoV-2 in real life. J Clin Virol. 2020 Aug 2:104569; doi: 10.1016/j.jcv.2020.104569.
160. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2. J Clin Virol. 2020 Aug 2:104572; doi: 10.1016/j.jcv.2020.104572.
159. The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions. Med Hypotheses. 2020 Aug 2:110155; doi: 10.1016/j.mehy.2020.110155.
158. Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19. Rheumatol Int. 2020 Aug 2:1–11; doi: 10.1007/s00296-020-04663-9.
157. Anaphylactic shock following diagnosis of COVID-19. Ann Allergy Asthma Immunol. 2020 Aug 1; doi: 10.1016/j.anai.2020.07.032.
156. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies. Biomed Pharmacother. 2020 Aug 1:110559; doi: 10.1016/j.biopha.2020.110559
155. Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology. Frontiers in Immunology, 2020;11:1642.
154. SCHOOL of nature: ligand-independent immunomodulatory peptides. Drug Discov Today. 2020 May 12; doi: 10.1016/j.drudis.2020.05.005
153. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Cell Metab. 2020 May 12; doi: 10.1016/j.cmet.2020.04.015
152. CD4+ T Cells at the Center of Inflammaging. Cell Metab. 2020 May 12; doi: 10.1016/j.cmet.2020.04.016
151. Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases. Diabetes Metab Syndr. 2020 May 12; doi: 10.1016/j.dsx.2020.05.023
150. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr. 2020 May 12; doi: 10.1016/j.dsx.2020.05.025
Pings en SCI reúne recursos sobre inmunidad y SARS-CoV-2